Correcting and replacing cybin announces up to usd$35 million at-the-market equity program

Toronto--(business wire)--first paragraph, first sentence of release should read: cybin inc. (neo: cybn) (nyse american: cybn) (“cybin” or the “company”), a biopharmaceutical company focused on progressing “psychedelics to therapeuticstm”, announced today that it has established an at-the-market equity program (the “atm program”) that allows cybin to issue and sell up to usd$35,000,000 of common shares (instead of cybin inc. (neo: cybn) (nyse american: cybn) (“cybin” or the “company”), a biopha
CYBN Ratings Summary
CYBN Quant Ranking